Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
GHK is intended strictly for in vitro research applications
FAQs Multiple companies are set to share data from Phase 3 trials including Bristol Myers Squibb, Cognito Therapeutics, and Eli Lilly
Ethical approval and consent to participate Not applicable
It is intended exclusively for in vitro testing and laboratory experiments
The lethal dose in humans would be approximately 21,000mg for a 70kg person, making the 1-3mg daily doses used in typical protocols extremely safe from a toxicity standpoint
Goldenberg Dermatology NYC was among the first board-certified dermatologists in New York to offer these revolutionary cellular regeneration hair loss technologies including PRP and Stem Cell hair loss therapy
US$ 28.80
US$ 29.73
US$ 27.10
US$ 23.87
